---
title: Large US stocks near their 52-week highs
canonical: https://sweetvaluelab.com/lists/near-52-week-highs
as_of: 2026-10-17
---
# Large US stocks near their 52-week highs

The latest close against the highest close of the last 52 weeks: closing prices, not intraday highs. A stock at or above its high reads 0%; ties at the high are ranked by how far the stock has risen from its 52-week low. Drawn from the 515 large US companies this site covers, as of Oct 17, 2026. The list ranks by that figure only; price vs model is a column, stated against the model and never as a call.

| # | Stock | Sector | From 52w high | Close | 52-week closing range | Price vs model |
| ---: | --- | --- | ---: | ---: | ---: | --- |
| 1 | APA (APA Corporation) | Energy | 0.0% | $49.15 | $21.66 – $49.15 | undervalued by 8% vs model |
| 2 | COP (ConocoPhillips) | Energy | 0.0% | $146.51 | $85.66 – $146.51 | undervalued by 24% vs model |
| 3 | WBD (Warner Bros. Discovery, Inc.) | Communication Services | 0.0% | $30.95 | $18.19 – $30.95 | overvalued by 137% vs model |
| 4 | WST (West Pharmaceutical Services, Inc.) | Healthcare | 0.0% | $384.02 | $230.95 – $384.02 | overvalued by 244% vs model |
| 5 | CAH (Cardinal Health, Inc.) | Healthcare | 0.0% | $254.06 | $156.41 – $254.06 | overvalued by 9% vs model |
| 6 | XOM (Exxonmobil Holdings Corporation) | Energy | 0.0% | $178.98 | $112.24 – $178.98 | overvalued by 13% vs model |
| 7 | EOG (EOG Resources, Inc.) | Energy | 0.0% | $158.01 | $101.78 – $158.01 | undervalued by 39% vs model |
| 8 | CVX (Chevron Corporation) | Energy | 0.0% | $224.98 | $146.75 – $224.98 | overvalued by 9% vs model |
| 9 | ADP (Automatic Data Processing, Inc.) | Technology | 0.0% | $288.90 | $188.79 – $288.90 | overvalued by 65% vs model |
| 10 | MET (MetLife, Inc.) | Financial Services | 0.0% | $100.76 | $67.70 – $100.76 | overvalued by 112% vs model |
| 11 | IFF (International Flavors & Fragrances Inc.) | Basic Materials | 0.0% | $90.68 | $61.49 – $90.68 | overvalued by 22% vs model |
| 12 | ABBV (AbbVie Inc.) | Healthcare | 0.0% | $285.42 | $197.38 – $285.42 | at model value |
| 13 | AAPL (Apple Inc.) | Technology | 0.0% | $343.46 | $246.63 – $343.46 | overvalued by 114% vs model |
| 14 | KO (The Coca-Cola Company) | Consumer Defensive | 0.0% | $93.90 | $67.54 – $93.90 | overvalued by 76% vs model |
| 15 | MCK (McKesson Corporation) | Healthcare | 0.0% | $1,004.84 | $725.17 – $1,004.84 | undervalued by 18% vs model |
| 16 | MO (Altria Group, Inc.) | Consumer Defensive | 0.0% | $75.11 | $54.72 – $75.11 | overvalued by 6% vs model |
| 17 | KDP (Keurig Dr Pepper Inc.) | Consumer Defensive | 0.0% | $34.62 | $25.31 – $34.62 | undervalued by 57% vs model |
| 18 | V (Visa Inc.) | Financial Services | 0.0% | $402.61 | $295.52 – $402.61 | overvalued by 40% vs model |
| 19 | CCEP (Coca-Cola Europacific Partners PLC) | Consumer Defensive | 0.0% | $112.40 | $85.43 – $112.40 | — |
| 20 | MA (Mastercard Incorporated) | Financial Services | 0.0% | $617.42 | $471.55 – $617.42 | overvalued by 15% vs model |
| 21 | PFE (Pfizer Inc.) | Healthcare | 0.0% | $29.58 | $23.67 – $29.58 | undervalued by 3% vs model |
| 22 | BRK-B (Berkshire Hathaway Inc.) | Financial Services | 0.0% | $532.14 | $465.40 – $529.42 | overvalued by 21% vs model |
| 23 | VTRS (Viatris Inc.) | Healthcare | 0.0% | $18.66 | $10.11 – $18.66 | overvalued by 81% vs model |
| 24 | ELV (Elevance Health Inc.) | Healthcare | 0.0% | $428.26 | $280.74 – $428.43 | undervalued by 20% vs model |
| 25 | TECH (Bio-Techne Corporation) | Healthcare | −0.1% | $72.57 | $43.30 – $72.61 | overvalued by 150% vs model |
| 26 | PM (Philip Morris International Inc.) | Consumer Defensive | −0.2% | $205.20 | $144.33 – $205.58 | overvalued by 19% vs model |
| 27 | RSG (Republic Services, Inc.) | Industrials | −0.3% | $231.54 | $197.73 – $232.27 | overvalued by 27% vs model |
| 28 | KMI (Kinder Morgan, Inc.) | Energy | −0.3% | $34.20 | $25.84 – $34.31 | overvalued by 5% vs model |
| 29 | CHD (Church & Dwight Co., Inc.) | Consumer Defensive | −0.7% | $104.53 | $81.60 – $105.26 | overvalued by 32% vs model |
| 30 | WSM (Williams-Sonoma, Inc.) | Consumer Cyclical | −0.7% | $250.16 | $168.64 – $252.03 | overvalued by 103% vs model |
| 31 | GILD (Gilead Sciences, Inc.) | Healthcare | −0.7% | $156.19 | $117.88 – $157.37 | undervalued by 16% vs model |
| 32 | VEEV (Veeva Systems Inc.) | Technology | −0.9% | $310.36 | $151.43 – $313.03 | overvalued by 157% vs model |
| 33 | TMO (Thermo Fisher Scientific Inc.) | Healthcare | −0.9% | $690.00 | $438.34 – $696.49 | overvalued by 78% vs model |
| 34 | CB (Chubb Limited) | Financial Services | −1.0% | $359.79 | $268.20 – $363.50 | overvalued by 21% vs model |
| 35 | MTD (Mettler-Toledo International Inc.) | Healthcare | −1.0% | $1,622.29 | $1,025.53 – $1,639.04 | overvalued by 148% vs model |
| 36 | BDX (Becton, Dickinson and Company) | Healthcare | −1.0% | $191.75 | $138.67 – $193.76 | undervalued by 14% vs model |
| 37 | BIIB (Biogen Inc.) | Healthcare | −1.1% | $232.65 | $143.00 – $235.35 | undervalued by 34% vs model |
| 38 | CTAS (Cintas Corporation) | Industrials | −1.3% | $213.69 | $163.55 – $216.53 | overvalued by 108% vs model |
| 39 | EXPD (Expeditors International of Washington, Inc.) | Industrials | −1.4% | $195.91 | $117.57 – $198.64 | overvalued by 80% vs model |
| 40 | PSX (Phillips 66) | Energy | −1.4% | $293.17 | $127.75 – $297.29 | overvalued by 154% vs model |
| 41 | MPC (Marathon Petroleum Corporation) | Energy | −1.4% | $478.07 | $162.63 – $484.92 | overvalued by 8% vs model |
| 42 | HLT (Hilton Worldwide Holdings Inc.) | Consumer Cyclical | −1.5% | $345.09 | $256.96 – $350.22 | overvalued by 177% vs model |
| 43 | A (Agilent Technologies, Inc.) | Healthcare | −1.5% | $172.97 | $110.24 – $175.55 | overvalued by 118% vs model |
| 44 | WAT (Waters Corporation) | Healthcare | −1.6% | $436.95 | $283.32 – $444.15 | overvalued by 73% vs model |
| 45 | MDLZ (Mondelez International, Inc.) | Consumer Defensive | −1.7% | $63.91 | $51.51 – $64.99 | overvalued by 88% vs model |
| 46 | EMR (Emerson Electric Co.) | Industrials | −1.8% | $161.47 | $123.30 – $164.38 | overvalued by 84% vs model |
| 47 | LLY (Eli Lilly and Company) | Healthcare | −1.8% | $1,257.03 | $799.57 – $1,280.34 | overvalued by 22% vs model |
| 48 | IQV (IQVIA Holdings Inc.) | Healthcare | −1.8% | $266.90 | $156.66 – $271.90 | overvalued by 12% vs model |
| 49 | CNC (Centene Corp.) | Healthcare | −1.9% | $69.16 | $31.80 – $70.51 | undervalued by 56% vs model |
| 50 | TRV (The Travelers Companies, Inc.) | Financial Services | −1.9% | $389.54 | $262.01 – $397.22 | overvalued by 51% vs model |

---

Source: https://sweetvaluelab.com/lists/near-52-week-highs (SweetValueLab, free, no account). Prices and statements from Financial Modeling Prep; filings from SEC EDGAR. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.